Janssen Pharmaceuticals Inc.
1125 Trenton-Harbourton Road
P.O. Box 200
Titusville
NJ
08560
800-775-5514
http://www.janssenpharmaceuticalsinc.com/

Related Content

Xarelto, rivaroxaban, PMSS study, ACC 2016, NVAF, atrial fibrillation, stroke
News | Antiplatelet and Anticoagulation Therapies
Real-world Study Confirms Safety Profile of Rivaroxaban for Non-Valvular AFib Patients

April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was ...

Home April 08, 2016
arrow
pulmonary embolism, low-risk PE, rivaroxaban, Xarelto, MERCURY PE trial
News | Pulmonary Embolism
Study Examines Anticoagulants as Outpatient Treatment for Stable Pulmonary Embolism

November 3, 2015 — Pulmonary embolism (PE) is a potentially life-threatening condition that occurs, for example, when a ...

Home November 03, 2015
arrow
Xarelto, PMSS, XANTUS, ESC 2015, major bleeding, non-valvular atrial fibrillation, NVAF
News | Antiplatelet and Anticoagulation Therapies
PMSS, XANTUS Trials Confirm Safety of Xarelto for Non-Valvular AFib Patients

September 4, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from ...

Home September 04, 2015
arrow
rivaroxaban, Xarelto, VENTURE-AF, VKA, atrial fibrillation, Heart Rhythm 2015
News
VENTURE-AF Trial Data Supports Rivaroxaban for Atrial Fibrillation Patients Undergoing Catheter Ablation

May 21, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from the ...

Home May 21, 2015
arrow
Xarelto, rivaroxaban, Starter Pack, FDA, deep vein thrombosis, pulmonary embolis
Technology
FDA Approves Rivaroxaban Starter Pack for Deep Vein Thrombosis and Pulmonary Embolism

March 4, 2015 — The U.S. Food and Drug Administration (FDA) has approved the Xarelto Starter Pack for deep vein ...

Home March 04, 2015
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now